rs615470

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000745.4(CHRNA5):​c.*393T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.645 in 156,536 control chromosomes in the GnomAD database, including 32,830 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.64 ( 31870 hom., cov: 33)
Exomes 𝑓: 0.66 ( 960 hom. )

Consequence

CHRNA5
NM_000745.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.527

Publications

45 publications found
Variant links:
Genes affected
CHRNA5 (HGNC:1959): (cholinergic receptor nicotinic alpha 5 subunit) The protein encoded by this gene is a nicotinic acetylcholine receptor subunit and a member of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. These receptors are thought to be heteropentamers composed of separate but similar subunits. Defects in this gene have been linked to susceptibility to lung cancer type 2 (LNCR2).[provided by RefSeq, Jun 2010]
CHRNA3 (HGNC:1957): (cholinergic receptor nicotinic alpha 3 subunit) This locus encodes a member of the nicotinic acetylcholine receptor family of proteins. Members of this family of proteins form pentameric complexes comprised of both alpha and beta subunits. This locus encodes an alpha-type subunit, as it contains characteristic adjacent cysteine residues. The encoded protein is a ligand-gated ion channel that likely plays a role in neurotransmission. Polymorphisms in this gene have been associated with an increased risk of smoking initiation and an increased susceptibility to lung cancer. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
CHRNA3 Gene-Disease associations (from GenCC):
  • urinary bladder, atony of
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.799 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNA5NM_000745.4 linkc.*393T>C 3_prime_UTR_variant Exon 6 of 6 ENST00000299565.9 NP_000736.2 P30532Q6EWN4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNA5ENST00000299565.9 linkc.*393T>C 3_prime_UTR_variant Exon 6 of 6 1 NM_000745.4 ENSP00000299565.5 P30532

Frequencies

GnomAD3 genomes
AF:
0.644
AC:
97904
AN:
151946
Hom.:
31834
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.599
Gnomad AMI
AF:
0.577
Gnomad AMR
AF:
0.757
Gnomad ASJ
AF:
0.654
Gnomad EAS
AF:
0.818
Gnomad SAS
AF:
0.697
Gnomad FIN
AF:
0.649
Gnomad MID
AF:
0.797
Gnomad NFE
AF:
0.628
Gnomad OTH
AF:
0.669
GnomAD4 exome
AF:
0.659
AC:
2948
AN:
4474
Hom.:
960
Cov.:
0
AF XY:
0.657
AC XY:
1567
AN XY:
2386
show subpopulations
African (AFR)
AF:
0.566
AC:
43
AN:
76
American (AMR)
AF:
0.772
AC:
366
AN:
474
Ashkenazi Jewish (ASJ)
AF:
0.675
AC:
54
AN:
80
East Asian (EAS)
AF:
0.845
AC:
120
AN:
142
South Asian (SAS)
AF:
0.689
AC:
175
AN:
254
European-Finnish (FIN)
AF:
0.679
AC:
72
AN:
106
Middle Eastern (MID)
AF:
0.333
AC:
2
AN:
6
European-Non Finnish (NFE)
AF:
0.635
AC:
1999
AN:
3150
Other (OTH)
AF:
0.629
AC:
117
AN:
186
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
59
118
177
236
295
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.644
AC:
97989
AN:
152062
Hom.:
31870
Cov.:
33
AF XY:
0.647
AC XY:
48101
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.599
AC:
24832
AN:
41474
American (AMR)
AF:
0.757
AC:
11564
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.654
AC:
2270
AN:
3470
East Asian (EAS)
AF:
0.819
AC:
4250
AN:
5188
South Asian (SAS)
AF:
0.699
AC:
3367
AN:
4818
European-Finnish (FIN)
AF:
0.649
AC:
6844
AN:
10540
Middle Eastern (MID)
AF:
0.786
AC:
231
AN:
294
European-Non Finnish (NFE)
AF:
0.628
AC:
42687
AN:
67990
Other (OTH)
AF:
0.673
AC:
1418
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1804
3608
5411
7215
9019
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
788
1576
2364
3152
3940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.636
Hom.:
77095
Bravo
AF:
0.650
Asia WGS
AF:
0.743
AC:
2584
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
6.9
DANN
Benign
0.90
PhyloP100
0.53
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs615470; hg19: chr15-78885988; API